A molecular pathway for cancer cachexia-induced muscle atrophy revealed at single-nucleus resolution
Cancer cachexia is a prevalent and often fatal wasting condition that cannot be fully reversed with nutritional interventions. Muscle atrophy is a central component of the syndrome, but the mechanisms whereby cancer leads to skeletal muscle atrophy are not well understood. We performed single-nucleu...
Saved in:
Published in | Cell reports (Cambridge) Vol. 43; no. 8; p. 114587 |
---|---|
Main Authors | , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Elsevier Inc
27.08.2024
Elsevier |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Cancer cachexia is a prevalent and often fatal wasting condition that cannot be fully reversed with nutritional interventions. Muscle atrophy is a central component of the syndrome, but the mechanisms whereby cancer leads to skeletal muscle atrophy are not well understood. We performed single-nucleus multi-omics on skeletal muscles from a mouse model of cancer cachexia and profiled the molecular changes in cachexic muscle. Our results revealed the activation of a denervation-dependent gene program that upregulates the transcription factor myogenin. Further studies showed that a myogenin-myostatin pathway promotes muscle atrophy in response to cancer cachexia. Short hairpin RNA inhibition of myogenin or inhibition of myostatin through overexpression of its endogenous inhibitor follistatin prevented cancer cachexia-induced muscle atrophy in mice. Our findings uncover a molecular basis of muscle atrophy associated with cancer cachexia and highlight potential therapeutic targets for this disorder.
[Display omitted]
•KIC is a pancreatic cancer model manifesting severe cancer cachexia-induced muscle atrophy•Multi-omics analysis reveals activation of denervation-responsive and catabolic genes in KIC muscle•Inhibition of the myogenin-myostatin axis rescues muscle atrophy in KIC mice
In this study, Zhang et al. show that denervation-responsive and catabolic genes are induced in cachexic muscle from a genetic mouse model of pancreatic cancer. The activation of a myogenin-myostatin axis drives muscle atrophy in this model, and muscle atrophy can be rescued by inhibiting myogenin or myostatin. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 2211-1247 2211-1247 |
DOI: | 10.1016/j.celrep.2024.114587 |